Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBIS phase 2 trial of 2-iminobiotin in acute ischemic stroke with large vessel occlusion
2021-002162-40Phase 2Completed
- Sponsor
- Haaglanden Medical Centre
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of 2-iminobiotin in ischemic stroke and Large vessel occlusion (LVO) (2 arms), sponsored by Haaglanden Medical Centre. Primary endpoints: Short-term safety and tolerability, Adverse events and 1 more. Started Feb 2022; status: completed.
02
Drugs
2-iminobiotin
03
Conditions
ischemic strokeLarge vessel occlusion (LVO)
Beyond the preview
Go deeper on 2021-002162-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002162-40.